While previous studies have suggested that mitochondrial dysfunction can promote ferroptosis and sensitize cancer cells to chemotherapy, our findings reveal that enhanced mitochondrial respiration, mediated by WBP1, can confer resistance to ferroptosis and chemotherapeutic agents in CRC cells. This evidence concerns the gene WBP1 and cancer.